Serafino Pantano
Novartis (Switzerland) · 26 works · 9,534 citations · h-index 18
Top works
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
- Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray
- p38-dependent marking of inflammatory genes for increased NF-κB recruitment
- Two Waves of Nuclear Factor κb Recruitment to Target Promoters
- Modulation of NF-κB Activity by Exchange of Dimers
- Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
- Presence of Endogenous Nicks in DNA of Ejaculated Human Spermatozoa and its Relationship to Chromomycin A3 Accessibility1
- Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
- Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury
- Transcriptome Analysis of Mouse Stem Cells and Early Embryos
- Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome
- PLAC1, an Xq26 Gene with Placenta-Specific Expression
- Agenesis of the Scapula in Emx2 Homozygous Mutants
- Emx 2 developmental expression in the primordia of the reproductive and excretory systems
- Phemx, a Novel Mouse Gene Expressed in Hematopoietic Cells Maps to the Imprinted Cluster on Distal Chromosome 7
- Vascular Origin of Vildagliptin-induced Skin Effects in Cynomolgus Monkeys
- Differential Control of Notch1 Gene Transcription by Klf4 and Sp3 Transcription Factors in Normal versus Cancer-Derived Keratinocytes
- Plastic downregulation of the transcriptional repressor BCL6 during maturation of human dendritic cells
- Genetic landscape of patients with ALK-rearranged non–small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study